Gilead Sciences Inc. (GILD) Stock | Share Price | US3755581036
GILD · Health Care ·
United States
Gilead Sciences Inc. (GILD) is a company in the Health Care sector, based in United States. The stock is held in 25 ETFs we track – with its largest weight of 2.86 % in XUHC (msci-usa-health-care). That means you can hold Gilead Sciences indirectly and diversified through an ETF savings plan.
Very high ETF coverage: 25 of the 95 ETFs we cover hold Gilead Sciences, spread across 13 indices. That puts the stock in more ETFs than 93.9 % of the 4,362 stocks we cover.
Price chart
Performance
| Year to date | +21.8 % | 1 year | +29.1 % |
|---|---|---|---|
| 1 month | +13.5 % | 3 months | +10.8 % |
| Calendar year 2025 | +32.9 % | ||
| Calendar year 2026 | +20.7 % |
Risk metrics
Correlated with
The strongest co-movers on top, the most inverse below. Low or negative values improve portfolio diversification.
| Instrument | r | −1 … +1 |
|---|---|---|
| Pfizer Inc. | +0.52 | |
| Amgen Inc. | +0.51 | |
| Bristol-Myers Squibb Company | +0.49 | |
| Royalty Pharma plc Class A | +0.49 | |
| Vertex Pharmaceuticals Incorporated | +0.49 | |
| Eli Lilly and Company | +0.44 | |
| GRAM | -0.39 | |
| Seagate Technology Holdings plc | -0.36 | |
| Western Digital Corporation | -0.29 |
Key financials
Latest reported fiscal year (FY2025, period end 2025-12-31) as filed with the SEC.
| Fiscal year | Revenue | Net income | Margin |
|---|---|---|---|
| FY2023 | 27.1 | 5.7 | 20.9 % |
| FY2024 | 28.8 | 0.5 | 1.7 % |
| FY2025 | 29.4 | 8.5 | 28.9 % |
Figures in USD bn. Source: SEC EDGAR (XBRL annual filings, public domain). US-listed SEC filers only.
Held in these ETFs
| ETF | Index | Weight |
|---|---|---|
| XUHC | msci-usa-health-care | 2.86 % |
| XUHL | msci-usa-health-care | 2.86 % |
| SPFS | msci-world-health-care | 2.13 % |
| XDWH | msci-world-health-care | 2.10 % |
| EXXT | nasdaq-100 | 0.82 % |
| XNAS | nasdaq-100 | 0.82 % |
| 2B7K | msci-world-sri | 0.81 % |
| XDEB | msci-world-minimum-volatility | 0.62 % |
| XDEV | msci-world-value | 0.46 % |
| XDEQ | msci-world-quality | 0.45 % |
| SXR8 | sp500 | 0.28 % |
| SPYL | sp500 | 0.28 % |
| SPY5 | sp500 | 0.28 % |
| XD9U | msci-usa | 0.28 % |
| XD9D | msci-usa | 0.28 % |
| EUNL | msci-world | 0.20 % |
| XDWD | msci-world | 0.20 % |
| SPPW | msci-world | 0.20 % |
| XDWL | msci-world | 0.20 % |
| SWWD | msci-world | 0.20 % |
| SPYI | msci-acwi-imi | 0.19 % |
| SPSA | msci-acwi-imi | 0.19 % |
| SPYY | msci-acwi | 0.18 % |
| WIMI | msci-world-imi | 0.18 % |
| IUSQ | msci-acwi | 0.17 % |
Want to know how much Gilead Sciences Inc. overlaps with the rest of your portfolio? Use the Portfolio X-Ray or the ETF overlap check.
Stocks with similar ETF exposure
Names that reach a portfolio through largely the same funds as Gilead Sciences — the figure counts the ETFs holding both.
Vertex Pharmaceuticals IncorporatedVRTX · 24 shared ETFs · r +0.49
IDEXX Laboratories Inc.IDXX · 23 shared ETFs
Amgen Inc.AMGN · 23 shared ETFs · r +0.51
Incyte CorporationINCY · 22 shared ETFs
Regeneron Pharmaceuticals Inc.REGN · 22 shared ETFs
DexCom Inc.DXCM · 22 shared ETFs
Cigna GroupCI · 22 shared ETFs
Elevance Health Inc.ELV · 22 shared ETFs
In the Alysly network
How Gilead Sciences Inc. connects to ETFs, indices and neighbouring names — every link is a measured relation, not a recommendation.
- MSCI USA Health Care Index · contains
- United States Country · domicile
- XUHL ETF · holds
- XUHC ETF · holds
- XDWH ETF · holds
- SPFS ETF · holds
- Health Care Sector · sector
- Amgen Stock · similar ETF exposure
- Vertex Pharmaceuticals Incorporated Stock · similar ETF exposure
Latest Investment Intelligence News: Stocks
· MixedPOL tumbles 9.4% – August 26, 2026
· MixedSTX climbs 12.6% – August 25, 2026
· Risk-offSelling pressure hits markets, with only 30% of assets higher – August 24, 2026
· MixedCrypto, commodities & FX this week: Sui -9.0% · August 17–21, 2026
· MixedThe week in markets: MSCI Emerging Markets sets the tone for the week (+1.6%) · August 17–21, 2026